InsidersTradesSigma
Browse the detailed record of transactions filed by Mattes Glenn R., Chairman & CEO. Insider active across 1 companies, notably TFF Pharmaceuticals, Inc.. Aggregated, 3 filings have been published. Total volume traded: €194k. The latest transaction was disclosed on 16 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Glenn R. Mattes is the Chief Executive Officer of TFF Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company, which focuses on developing innovative pharmaceutical solutions. Mattes is committed to advancing the company's mission.